What is Zymeworks's investing cash flow?

Zymeworks (ZYME) reported investing cash flow of $69.96M in Q1 2026.

How has Zymeworks's investing cash flow changed year-over-year?

Zymeworks's investing cash flow increased by 474.3% year-over-year, from $12.18M to $69.96M.

What is the long-term trend for Zymeworks's investing cash flow?

Over 3 years (2021 to 2025), Zymeworks's investing cash flow has grown at a -43.1% compound annual growth rate (CAGR), from $144.6M to $26.66M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Zymeworks ZYME Investing Cash Flow

Investing Cash Flow at other companies

PfizerPFE

$785M-76.0%

AmgenAMGN

-$716M-60.2%

AnaptysBio, Inc.ANAB

$34.98M+136%

Viridian Therapeutics, Inc.VRDN

$77.26M-22.8%

AbCellera Biologics Inc.ABCL

-$25.08M-416%

Stoke Therapeutics, Inc.STOK

$50.69M+272%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's investing cash flow?: Zymeworks (ZYME) reported investing cash flow of $69.96M in Q1 2026.
How has Zymeworks's investing cash flow changed year-over-year?: Zymeworks's investing cash flow increased by 474.3% year-over-year, from $12.18M to $69.96M.
What is the long-term trend for Zymeworks's investing cash flow?: Over 3 years (2021 to 2025), Zymeworks's investing cash flow has grown at a -43.1% compound annual growth rate (CAGR), from $144.6M to $26.66M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.